This volume celebrates progress made in four decades, and more importantly, it provides a clear indication of the complex biology that needs further investigation to realize the possibilities envisioned for this beneficial therapeutic ...
eBook Title: Antiangiogenic Cancer Therapy
Author:Darren W. Davis,Roy S. Herbst,James L. Abbruzzese
Published on 2007-07-25 by CRC Press
Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors. Compiles the results of four decades of progress Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject. Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment. Covers specific molecular targets for inhibiting angiogenesis in cancer therapy. Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors. Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers. This volume celebrates progress made in four decades, and more importantly, it provides a clear indication of the complex biology that needs further investigation to realize the possibilities envisioned for this beneficial therapeutic modality.
From the most popular Blood Cancer Symptoms Books, Antiangiogenic Cancer Therapy is the one of great book to have. You can download ebook from:
Darren W. Davis,Roy S. Herbst,James L. Abbruzzese
entitled: Antiangiogenic Cancer Therapy here. There are so many ebooks about Antiangiogenic Cancer Therapy that are available to download. Thinking of having free ebooks by Download Antiangiogenic Cancer Therapy ebook rather than buy? You are in the right place. Download ebook Antiangiogenic Cancer Therapy by:Darren W. Davis,Roy S. Herbst,James L. Abbruzzese.
- Book was ranked at 20 by Google Books for Antiangiogenic Cancer Therapy
- Antiangiogenic Cancer Therapy published by CRC Press since 2007-07-25 with ISBNs. The book ISBN 13 Code is 9781420004298 and ISBN 10 Code is 1420004298
- Reading Mode in Text Status is false and Reading Mode in Image Status is true
- The book has "864 Pages" is Printed at BOOK underScienceCategory
- Rated by Raters and have average rate at ""
- eBook Maturity (Adult Book) status is NOT_MATURE
- eBook written in en
- Book Preview Address: http://books.google.com/books?id=jllIVOYuqFgC&printsec=frontcover&dq=Blood+Cancer+Symptoms&hl=&cd=219&source=gbs_api
Book Preview
- Server 1: FAST DOWNLOAD
- Server 2: SECURE DOWNLOAD
- Server 3: FAST DOWNLOAD